Strata Critical Medical, Inc. (SRTA): M&A transaction — Strata Critical Medical amends 8-K to include Keystone financials; acquisition closed

Strata Critical Medical, Inc.

Acquisition of Keystone Perfusion Services closed Sep 16, 2025; all equity interests acquired.
Keystone's audited FY2024: revenue $42.9M, net income $2.97M, total assets $16.9M.
Amendment adds historical audited and unaudited financials of Keystone and pro forma combined statements.
Sale of Passenger business to Joby Aero also referenced as part of overall transactions.
Pro forma financials for FY2024, FY2023, and nine months ended Sep 30, 2025 filed as Exhibit 99.3.

item 9.01 item 2.01

Key facts

Extracted from this filing and checked against the source text.

M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.9

Strata Critical Medical, Inc. completed an acquisition involving Keystone Perfusion Services, LLC (closed 2025-09-16).

Action: acquisition
Counterparty: Keystone Perfusion Services, LLC
Closing: 2025-09-16

Exact text from the filing

the completion of the acquisition of Keystone Perfusion Services, LLC ("Keystone") by way of acquiring all the issued and outstanding equity interests of Keystone

View on SEC.gov

Browse all m&a transactions →

Strata Critical Medical, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-25-054709

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.